View in EDS HTML Full Text PDF Full Text

Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention.

Saved in:
Bibliographic Details
Title: Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention.
Authors: Li, Yan-Ruide1 (AUTHOR), Dunn, Zachary Spencer2 (AUTHOR), Garcia Jr., Gustavo3 (AUTHOR), Carmona, Camille1 (AUTHOR), Zhou, Yang1 (AUTHOR), Lee, Derek1 (AUTHOR), Yu, Jiaji1 (AUTHOR), Huang, Jie1 (AUTHOR), Kim, Jocelyn T.4 (AUTHOR), Arumugaswami, Vaithilingaraja3,5 (AUTHOR), Wang, Pin2 (AUTHOR), Yang, Lili1,5,6,7 (AUTHOR) liliyang@ucla.edu
Source: Stem Cell Research & Therapy. 3/21/2022, Vol. 13 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17576512
DOI:10.1186/s13287-022-02787-2